DSGN

Design Therapeutics (DSGN)

About Design Therapeutics (DSGN)

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Details

Daily high

$12.57

Daily low

$11.92

Price at open

$12.50

52 Week High

$12.84

52 Week Low

$2.60

Market cap

770.3M

Dividend yield

0.00%

Volume

193,632

Avg. volume

349,569

P/E ratio

-10.25

Design Therapeutics News